Autosomal Dominant/X Linked Nonsyndromic Hearing Loss Panel (30 Genes)
| TEST CODE | MGT0030 |
| TEST NAME | Autosomal Dominant/X Linked Nonsyndromic Hearing Loss Panel (30 Genes) |
| RELATED GENE | ACTG1, CCDC50, COCH, COL11A2, CRYM, DFNA5, DIABLO, DIAPH1, DIAPH3, EYA4, GJB2, GJB3, GJB6, GRHL2, KCNQ4, MIR96, MYH14, MYH9, MYO6, MYO7A, PO3F4, POU4F3, PRPS1, SMPX, SIX1, SLC17A8, TECTA, TJP2, TCM1, WFS1 |
| SYNONYMOUS | ACTG1, CCDC50, COCH, COL11A2, CRYM, DFNA5, DIABLO, DIAPH1, DIAPH3, EYA4, GJB2, GJB3, GJB6, GRHL2, KCNQ4, MIR96, MYH14, MYH9, MYO6, MYO7A, PO3F4, POU4F3, PRPS1, SMPX, SIX1, SLC17A8, TECTA, TJP2, TCM1, WFS1 |
| OMIM | |
| HEREDITY | |
| CLINICAL AREA | Nonsyndromic hearing loss is partial or complete hearing loss that is not associated with any signs or symptoms. It accounts for 70% of genetic hearing losses. 30 autosomal dominant and X-linked inherited disease-related genes are examined within the scope of the panel. |
| METHOD | Next Generation Sequencing (NGS) |
| SAMPLE TYPE | Blood with EDTA |
| QUANTITY | 3 mL |
| TAT | 40 DAYS |
ORDER OPTIONS AND PRICING
Discover genetic insights at your convenience. Contact Mikrogen anytime for information on order options, pricing, and comprehensive genetic testing services